Prexigebersen is under clinical development by Bio-Path and currently in Phase II for Relapsed Acute Myeloid Leukemia.

A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.

A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to ...

Before discussing the different types of treatments, it’s helpful to understand common approaches to treatment for the different types of leukemia. You may find it useful to zero in on the type you ...

Prexigebersen is under clinical development by Bio-Path and currently in Phase II for Refractory Acute Myeloid Leukemia. According to GlobalData, Phase II drugs for Refractory Acute Myeloid Leukemia ...

Acute lymphocytic leukaemia (ALL) is a cancer of the blood and bone marrow, specifically affecting lymphocytes. The disease progresses rapidly and creates immature blood cells, rather than mature ...

Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would ...

New treatments and adverse events impacting patient quality of life were among the topics of interest in 2024.

If you have been diagnosed with acute myeloid leukemia or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. See the latest estimates for new ...

Hematologist-oncologists are doctors who specialize in treating blood cancers such as acute lymphoblastic leukemia (ALL). ALL is a rare, rapidly progressing cancer of the blood and bone marrow.

Ellissa was diagnosed with acute myeloid leukaemia - a cancer of the myeloid line of blood cells, characterised by the rapid ...

Colorado physicians helped research a new treatment protocol for the most common form of childhood cancer that has “instantly ...